Eisenberg J, Asnis G M, van Praag H M, Vela R M
Department of Psychiatry, Ezrath Nashim Hospital, Jerusalem, Israel.
J Clin Psychiatry. 1988 May;49(5):193-5.
A single-blind study was conducted to evaluate the effect of oral tyrosine on attention deficit disorder (ADD) with hyperactivity in seven outpatient children. Since most biological evidence of ADD supports a norepinephrine or dopamine deficiency, the authors hypothesized that tyrosine, which has been shown to increase catecholamine synthesis, would be beneficial in the treatment of ADD. None of the subjects, however, showed any significant improvement with tyrosine. Implications for the catecholamine deficiency hypothesis and treatment strategies for ADD are discussed.
开展了一项单盲研究,以评估口服酪氨酸对7名门诊多动症儿童注意力缺陷多动障碍(ADD)的影响。由于ADD的大多数生物学证据支持去甲肾上腺素或多巴胺缺乏,作者推测,已被证明可增加儿茶酚胺合成的酪氨酸,对ADD治疗有益。然而,没有一名受试者使用酪氨酸后有任何显著改善。文中讨论了儿茶酚胺缺乏假说的意义及ADD的治疗策略。